We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
-29.4%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$106M
AUM Growth
-$49.2M
Cap. Flow
+$4.09M
Cap. Flow %
3.87%
Top 10 Hldgs %
82.96%
Holding
60
New
6
Increased
11
Reduced
8
Closed
8

Top Buys

Rank Stock Value
1
EQM
EQM Midstream Partners, LP
EQM
+$2.38M
2
CELG
Celgene Corp
CELG
+$2.13M
3
CMTA
Clementia Pharmaceuticals Inc.
CMTA
+$1.24M
4
QDEL icon
QuidelOrtho
QDEL
+$782K
5
NBIX icon
Neurocrine Biosciences
NBIX
+$671K

Top Sells

Rank Stock Value
1
CFRX
ContraFect Corporation
CFRX
+$1.1M
2
EQT icon
EQT Corp
EQT
+$938K
3
OVV icon
Ovintiv
OVV
+$629K
4
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$397K
5
AXGN icon
Axogen
AXGN
+$369K

Sector Composition

Rank Sector Weight
1 Healthcare 95.72%
2 Energy 3.02%
3 Materials 0.13%
4 Industrials 0.12%
5 Consumer Staples 0.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TGTX icon
51
TG Therapeutics
TGTX
$8.39B
$62K 0.06%
15,000
– –
WKHS icon
52
Workhorse Group
WKHS
$30.1M
$13K 0.01%
8
– –
AXGN icon
53
Axogen
AXGN
$2.09B
– –
-10,000
Closed -$369K
OPK icon
54
Opko Health
OPK
$906M
– –
-103,956
Closed -$360K
SLDB icon
55
Solid Biosciences
SLDB
$843M
– –
-400
Closed -$283K
BIOL
56
DELISTED
Biolase, Inc.
BIOL
– –
-16
Closed -$83K
AVEO
57
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
– –
-12,000
Closed -$397K
GNCA
58
DELISTED
Genocea Biosciences, Inc.
GNCA
– –
-23,625
Closed -$147K
TSRO
59
DELISTED
TESARO, Inc.
TSRO
– –
-8,200
Closed -$320K
ECYT
60
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-14,000
Closed -$249K
1 2
3

Similar funds

RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BAM
Boyar Asset Management New York $176M AUM 20.04% 1-Year Est. Return
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
FPW
Flywheel Private Wealth Los Altos, California $176M AUM 26.12% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $176M AUM
PFA
Providence Financial Advisors Overland Park, Kansas $175M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return

Birchview Capital's Q4 2018 Portfolio in Review

As of Q4 2018, Birchview Capital held 60 positions worth $106M, down 32% from $155M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Birchview Capital deployed $4.09M of net new capital in Q4 2018, opening 6 new positions and adding to 11 existing holdings. Its largest new stake was EQM Midstream Partners, LP: 50,000 shares worth $2.16M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 97% a quarter earlier, followed by Energy and Materials.

On the sell side, the largest reduction was ContraFect Corporation, an estimated $1.1M trimmed.

  • Birchview Capital's largest Q4 2018 buy was EQM Midstream Partners, LP: 50,000 shares worth $2.16M.
  • Birchview Capital added most to Celgene Corp in Q4 2018, an estimated $2.13M increase.
  • Birchview Capital's biggest Q4 2018 reduction was ContraFect Corporation, cutting an estimated $1.1M.
  • Birchview Capital fully exited AVEO Pharmaceuticals, Inc. in Q4 2018, selling an estimated $397K.
  • Birchview Capital's ten largest holdings make up 83% of its $106M portfolio in Q4 2018.
  • Birchview Capital opened 6 new positions and closed 8 in Q4 2018.
  • Birchview Capital's portfolio value fell 32% quarter-over-quarter to $106M.

Based on Birchview Capital's 13F filing for Q4 2018, filed 6 Feb 2019.